1. Home
  2. PHIO vs SINT Comparison

PHIO vs SINT Comparison

Compare PHIO & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

N/A

Current Price

$1.21

Market Cap

12.5M

Sector

Health Care

ML Signal

N/A

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

N/A

Current Price

$2.73

Market Cap

11.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PHIO
SINT
Founded
2011
1996
Country
United States
United States
Employees
5
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
11.7M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
PHIO
SINT
Price
$1.21
$2.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$10.67
$16.00
AVG Volume (30 Days)
7.5M
29.1K
Earning Date
06-17-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,887,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$80.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.90
52 Week Low
$0.81
$1.72
52 Week High
$4.19
$6.78

Technical Indicators

Market Signals
Indicator
PHIO
SINT
Relative Strength Index (RSI) 56.30 37.23
Support Level $1.03 $2.55
Resistance Level $1.43 $2.94
Average True Range (ATR) 0.11 0.13
MACD 0.01 0.00
Stochastic Oscillator 55.39 18.97

Price Performance

Historical Comparison
PHIO
SINT

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Share on Social Networks: